Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

This article reviews the published literature on the use of venlafaxine, fluoxetine, and paroxetine for the treatment of hot flashes.

If you’ve ever felt that sudden, overwhelming wave of heat—the telltale sign of a hot flash—you know how disruptive and ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

As I was taking a psyco-social medical history of a 43-year-old woman, I asked, “What is your problem?” She replied, “I can’t sleep at night, I can’t seem to remember anything, my muscles hurt, ...

Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

New research published in Menopause, the journal of The Menopause Society, found a possible link between severe menopause ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Medically reviewed by Renita White, MD Perimenopause is the transition period when the female body starts to shift from ...

Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...